Relation Between Skin Cancer Medication and Dermatologic Adverse Events

May 07, 2021

A study at AAD VMX 2021 presented data on possible association between sex, skin cancer medication, and dermatologic adverse events.

FDA Accepts NDA, Sets Action Date for Apremilast
What’s Trending in Skin Care? May 2021
Study: SGX301 Demonstrates Efficacy for Treatment of Cutaneous T-cell Lymphoma
FDA Grants Orphan Drug Status to ITIL-168 for Melanoma